We are live on ! Find out more
Aster Capital Management

Aster Capital Management Portfolio holdings

AUM $275M Turnover 72.56%
1-Year Est. Return 18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
Cap. Flow
-$180M
Cap. Flow %
-65.37%
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.57M
2
OVV icon
Ovintiv
OVV
+$3.99M
3
KIM icon
Kimco Realty
KIM
+$3.52M
4
ALAB icon
Astera Labs
ALAB
+$3.33M
5
HUT icon
Hut 8
HUT
+$2.16M

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$11.3M
2
AAPL icon
Apple
AAPL
+$7.75M
3
MSFT icon
Microsoft
MSFT
+$6.82M
4
HON icon
Honeywell
HON
+$6.34M
5
KO icon
Coca-Cola
KO
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 16.08%
2 Technology 15.72%
3 Industrials 13.9%
4 Healthcare 13.43%
5 Consumer Discretionary 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PTON icon
626
Peloton Interactive
PTON
$2.26B
$33.1K 0.01%
+6,636
New +$37.1K
2026 Q3
0 quarters
NWBI icon
627
Northwest Bancshares
NWBI
$2.12B
$32.9K 0.01%
+2,219
New +$34.2K
2026 Q3
0 quarters
GOLF icon
628
Acushnet Holdings
GOLF
$4.63B
$32.9K 0.01%
+399
New +$38K
2026 Q3
0 quarters
SONO icon
629
Sonos
SONO
$2.01B
$32.6K 0.01%
+1,824
New +$28.3K
2026 Q3
0 quarters
RARE icon
630
Ultragenyx Pharmaceutical
RARE
$1.76B
$32.5K 0.01%
2,161
+1,902
+734% +$45.7K
2025 Q4
3 quarters
TEX icon
631
Terex
TEX
$5.96B
$32.4K 0.01%
+616
New +$39.2K
2026 Q3
0 quarters
AEIS icon
632
Advanced Energy
AEIS
$8.59B
$32.1K 0.01%
114
-6,130
-98% -$1.79M
2026 Q1
2 quarters
CSCO icon
633
Cisco
CSCO
$373B
$32.1K 0.01%
+298
New +$33.6K
2026 Q3
0 quarters
RBRK icon
634
Rubrik
RBRK
$23.7B
$31.6K 0.01%
+276
New +$25.4K
2026 Q3
0 quarters
SHOO icon
635
Steven Madden
SHOO
$2.97B
$31.4K 0.01%
+701
New +$30.9K
2026 Q3
0 quarters
BMRN icon
636
BioMarin Pharmaceuticals
BMRN
$11.9B
$31.3K 0.01%
521
-8,467
-94% -$533K
2025 Q4
3 quarters
BBNX icon
637
Beta Bionics
BBNX
$724M
$31.2K 0.01%
+1,645
New +$29.5K
2026 Q3
0 quarters
META icon
638
Meta Platforms (Facebook)
META
$1.52T
$31.2K 0.01%
43
-6,874
-99% -$4.29M
2026 Q1
2 quarters
MNOV icon
639
MediciNova
MNOV
$65.1M
$30.7K 0.01%
+18,322
New +$30.1K
2026 Q3
0 quarters
ON icon
640
ON Semiconductor
ON
$25.6B
$30.6K 0.01%
398
-4,206
-91% -$338K
2025 Q4
3 quarters
KALU icon
641
Kaiser Aluminum
KALU
$1.61B
$30.6K 0.01%
+211
New +$34.4K
2026 Q3
0 quarters
CSL icon
642
Carlisle Companies
CSL
$15B
$30K 0.01%
+93
New +$32.3K
2026 Q3
0 quarters
ENB icon
643
Enbridge
ENB
$102B
$29.9K 0.01%
644
+94
+17% +$4.86K
2025 Q1
6 quarters
RY icon
644
Royal Bank of Canada
RY
$260B
$29.9K 0.01%
+152
New +$31.6K
2026 Q3
0 quarters
ABSI icon
645
Absci
ABSI
$1.41B
$29.8K 0.01%
+2,764
New +$25.3K
2026 Q3
0 quarters
CCS icon
646
Century Communities
CCS
$1.37B
$29.8K 0.01%
+494
New +$32.7K
2026 Q3
0 quarters
HNI icon
647
HNI
HNI
$3.49B
$29.7K 0.01%
+656
New +$30K
2026 Q3
0 quarters
LEVI icon
648
Levi Strauss
LEVI
$9.02B
$29.5K 0.01%
1,497
-61
-4% -$1.37K
2026 Q2
1 quarter
TILE icon
649
Interface
TILE
$1.76B
$29.5K 0.01%
+857
New +$30.4K
2026 Q3
0 quarters
WAFD icon
650
WaFd
WAFD
$2.04B
$29.5K 0.01%
+985
New +$35.3K
2026 Q3
0 quarters

Similar funds

Aster Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.

  • Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
  • Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
  • Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
  • Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
  • Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
  • Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
  • Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.